Post-earnings recap
Reported
Thu, May 4, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Regeneron's earnings report showed a miss on EPS, yet the stock reacted positively, rising by 6.7%. Investors may be encouraged by management's focus on future growth and ongoing R&D investments. The lack of guidance might leave some uncertainty, but the overall tone suggests confidence in upcoming developments.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.92 | N/A | -10.51% |
Overall, management conveyed a positive outlook on future product launches despite the EPS miss. They emphasized the importance of innovation.
Management expressed confidence in the long-term growth prospects of their pipeline.
They highlighted ongoing investments in research and development.